Ranolazine Dihydrochloride (CAS 95635-56-6): ISO Certified 99% Purity for Chronic Angina & Cardiovascular Research
Discover Ranolazine Dihydrochloride, an ISO certified, high-purity (99%) pharmaceutical intermediate. Essential for chronic angina and cardiovascular disease research, it's a vital component for advanced drug development and effective patient care.
Get a Quote & SampleProduct Core Value
Ranolazine Dihydrochloride
Ranolazine Dihydrochloride stands as a pivotal pharmaceutical intermediate, renowned for its exceptional purity and multifaceted therapeutic potential. As an ISO certified reference material, it guarantees reliability for critical research and development in the cardiology sector.
- Explore the efficacy of Ranolazine Dihydrochloride for chronic angina management, a key area of its therapeutic application.
- Leverage ISO certified Ranolazine Dihydrochloride manufacturer standards to ensure unparalleled quality in your pharmaceutical formulations.
- Investigate its significant antiarrhythmic properties, making Ranolazine Dihydrochloride a valuable asset in heart rhythm disorder studies.
- Source Ranolazine Dihydrochloride API price competitively for large-scale production, ensuring cost-effectiveness without compromising on quality.
Product Advantages
Unmatched Purity & Certification
Our high purity (99%) Ranolazine Dihydrochloride is rigorously tested and ISO certified, ensuring consistent quality for critical pharmaceutical applications and research.
Dual Therapeutic Action
As both an antianginal agent and a compound with antiarrhythmic properties, Ranolazine Dihydrochloride offers a versatile approach to managing various cardiovascular conditions.
Targeted Physiological Impact
Ranolazine Dihydrochloride acts as a unique pyruvate dehydrogenase activator and late sodium current inhibitor, optimizing myocardial function and reducing ischemia.
Key Applications
Chronic Angina Treatment
Ranolazine Dihydrochloride is primarily utilized in the treatment of chronic angina, providing relief from chest pain and improving patient quality of life.
Antiarrhythmic Therapy Development
Its proven antiarrhythmic therapy potential makes it invaluable for developing new treatments for various heart rhythm disorders, including recurrent ventricular tachycardia.
Advanced Cardiovascular Research
Essential for cardiovascular research, this compound helps scientists explore complex mechanisms of heart disease and potential therapeutic pathways.
Pharmaceutical API Manufacturing
As a crucial pharmaceutical API production component, Ranolazine Dihydrochloride is central to manufacturing high-quality medications for cardiac care.